• Updated 08.10.2019 by Administrator UMB

    Research & Science

    The Medical University of Białystok (UMB) is one of the most dynamic medical academies in Central and Eastern Europe and has been carrying out an innovative science policy for years.

    UMB is the precursor and leader in innovative large-scale research covering particularly innovative technologies associated with development of artificial intelligence in medicine, genomics, proteomics, metabolomics, radiomics, and bioinformatics. UMB established the first Artificial Intelligence in Medicine Centre in this part of Europe, which is based on generation of top quality comprehensive databases from patients suffering from civilisation diseases. UMB is the leader in quality biobanking of biological material obtained from patients suffering from civilisation diseases. Furthermore, the Medical University is conducting population research, which is unique to this part of Europe and covers ten thousand inhabitants of Białystok (Białystok Plus). In cooperation with the National Centre for Research and Development, UMB is also carrying out unique research in scope of personalised medicine and civilisation diseases, including the project developing a reference biobanking model and service supporting the diagnosis and treatment of non-small-cell lung carcinoma in its early stages (MOBIT). This project has led to the development of a unique database, which includes the results of analyses of the entire genome of several hundred people suffering from non-small-cell lung carcinoma. The next project will involve development of the innovative VAMP (Voice Analysis for Medical Professionals) computer diagnosis system, which may improve early diagnosis of civilisation diseases, mental illnesses, and neurodegenerative changes. It will allow the medical diagnosis process to be started not only during a medical examination, but also at the time of a telephone call. The Academy focuses on teamwork of brilliant scientists in the most innovative research areas with involvement of international partners, which is reflected in the project obtained from the Foundation for Polish Science in scope of the TEAM programme aimed at explaining the role of intramuscular lipid accumulation in inducing insulin resistance in muscles. The conducted studies will help establish the impact of specific lipid groups on the activeness of the insulin pathway and allow for identification of its critical points, which are weakened by intramuscular lipid accumulation. The results of the project will provide the information required to establish new objectives in therapy of insulin resistance and type 2 diabetes.

    The academy has a state-of-the-art research and education base and a well-equipped apparatus park and laboratories, including the Euro-Regional Centre of Pharmacy, the Experimental Medicine Centre with GLP certification, the Clinical Research Centre, the Innovative Research Centre, the Bioinformatics and Data Analysis Centre, the innovative resources of the clinical hospital, the Biobank, the Artificial Intelligence Centre, and the UMB Molecular Imaging and Technological Development Laboratory.

    The highly skilled Academic faculty (800 academic teachers including 120 professors and 150 doctors) can take advantage of the commonly available development programmes, which cover study visits and training courses at the leading research centres worldwide. The academy remains in close relations with international research centres, carries out joint science projects, and hosts brilliant professors and scientists from around the world, including from institutions such as the Mayo Clinic, National Institute of Health in Bethesda, Harvard Medical School, University of Pennsylvania, Universitätsmedizin Greifswald, Universidad CEU San Pablo, Madrid, and the China Agricultural University. Around 25% of the publications created at UMB result from active international cooperation with partners of leading research centres abroad.

    The researchers of the Medical University of Białystok are actively patenting and commercialising their scientific inventions and the academy is open to cooperation with various business entities. The most recent UMB patents include Medical Honey – a product based on propolis extract, which stunts development of brain glioma, a UMB-licensed product strengthening the bees of LOB, synthetic saliva, and the work on the fungus from the Białowieża forest, which may help treat colon cancer in the future. 

    During the years 2012-2017, the academy obtained the KNOW certificate and was recognised by the Minister of Science and Higher Education as a Leading National Research Centre.

    The most important successes of UMB include establishment of the International Interdisciplinary Doctoral Studies in Medical Biology and Biostatistics. The funding was granted by the European Commission in scope of COFUND: Marie Skłodowska-Curie Actions of the Horizon 2020 Framework Programme, a prestigious European competition. The project also received funding from the Ministry of Science and Higher Education. UMB is the only Polish academy, which received funding from the COFUND competition in scope of the prestigious Marie Skłodowska-Curie Actions.

    In November of 2018, the Minister of Science and Higher Education entered the Medical University of Białystok into the group of the top 20 out of the almost 400 academies in the country and granted financial support towards the project entitled “Strategy of Perfection of the Medical University of Białystok – Research Academy of the Future” as action preparing for reception of the prestigious status of a “Research Academy”.

    The University published two periodicals, including Advances in Medical Sciences (IF 2.064) recognised on the ISI Master Journal List and Progress in Health Sciences, which is on the list of the Minister of Science and Higher Education.

    At present time, there are 5200 active students at the Medical University enrolled in 15 fields of study. Almost 400 of them are studying in English. Our foreign students come from 30 countries, including Norway, Sweden, the United States, Canada, Germany, Spain, and Saudi Arabia. The Academy’s education offer is regularly adapted to the needs of the labour market. The level of education provided by UMB is reflected in the high marks of our graduates in the Final Medical Exam and the Final Medical and Dental Exam.

    The Academy’s priorities include dynamic internationalisation. The Internationalisation Strategy is being implemented since 2018, there is an International Cooperation Officer and the International Cooperation Department. UMB has obtained funds from the National Agency for Academic Exchange towards four projects aimed at development of internationalisation. The Academy has also procured funds to apply for international accreditations.

    We are the bridge between the science of the East and West. We actively react to the health needs of the public. The Clinical Research Centre conducts performance testing for the athletes of Jagiellonia Białystok, the second football team in the country.

    The University is located in the 18th-century baroque Palace, which is referred to Versailles of the North and is located in the city centre. The building’s undergrounds house the innovative multimedia museum dedicated to the history of the Academy and Białystok. There are didactic buildings, two clinical hospitals, student houses, and sports facilities located nearby.

    The Medical University of Białystok is almost 70 years of tradition, 30 thousand graduates, and medical innovations.

    THIS IS WHERE DISCOVERIES ARE BORN!

     

    OFFICE FOR SCIENCE

    ul. Jana Kilińskiego 1

    15-098 Białystok

    Poland

    tel. +48 85 748 5412

    e-mail: dzialnau@umb.edu.pl